CD274 and neoplasm: Recent meta-analysis reports on the association between PD-L1 and immune checkpoint inhibitor treatment efficacy have shown no survival benefit of immune checkpoint inhibitor-based regimens compared to chemotherapy alone in subgroups with tumor proportion scores of less than 1% (23).